Nocita (bupivacaine liposome injectable suspension)

Aratana Therapeutics has announced FDA approval for Nocita (bupivacaine liposome injectable suspension) as a local postoperative analgesia for cranial cruciate ligament surgery in dogs. The company anticipates Nocita will be commercially available to veterinarians in the fall of 2016. The drug is a long-acting, local anesthetic that lasts up to 72 hours after surgery by releasing bupivacaine over time from multivesicular liposomes deposited in the tissue. The therapeutic is administered as a single dose by tissue infiltration during closure of cranial cruciate ligament surgery in dogs.

11400 Tomahawk Creek Parkway, Suite 340 Leawood, KS 66211
Tel: 1-844-744-7389